These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 24126144)

  • 1. Genomic and systems approaches to translational biomarker discovery in immunological diseases.
    MacIsaac KD; Wang IM; Menetski J; Roberts C
    Drug Discov Today; 2014 Feb; 19(2):133-9. PubMed ID: 24126144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomics and transcriptomics in drug discovery.
    Dopazo J
    Drug Discov Today; 2014 Feb; 19(2):126-32. PubMed ID: 23773860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translational bioinformatics and systems biology approaches for personalized medicine.
    Yan Q
    Methods Mol Biol; 2010; 662():167-78. PubMed ID: 20824471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leveraging biomarker platforms and systems biology for rehabilomics and biologics effectiveness research.
    Kobeissy FH; Guingab-Cagmat JD; Razafsha M; O'Steen L; Zhang Z; Hayes RL; Chiu WT; Wang KK
    PM R; 2011 Jun; 3(6 Suppl 1):S139-47. PubMed ID: 21703572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-21 as a new therapeutic target for immune-mediated diseases.
    Monteleone G; Pallone F; Macdonald TT
    Trends Pharmacol Sci; 2009 Aug; 30(8):441-7. PubMed ID: 19616319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JAK inhibition as a therapeutic strategy for immune and inflammatory diseases.
    Schwartz DM; Kanno Y; Villarino A; Ward M; Gadina M; O'Shea JJ
    Nat Rev Drug Discov; 2017 Dec; 16(12):843-862. PubMed ID: 29104284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systems biology in drug discovery.
    Butcher EC; Berg EL; Kunkel EJ
    Nat Biotechnol; 2004 Oct; 22(10):1253-9. PubMed ID: 15470465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systems biology approach to integrative comparative genomics.
    Lin J; Qian J
    Expert Rev Proteomics; 2007 Feb; 4(1):107-19. PubMed ID: 17288519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applying systems biology in drug discovery and development.
    Galizzi JP; Lockhart BP; Bril A
    Drug Metabol Drug Interact; 2013; 28(2):67-78. PubMed ID: 23612649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systems biology meets -omic technologies: novel approaches to biomarker discovery and companion diagnostic development.
    Caberlotto L; Lauria M
    Expert Rev Mol Diagn; 2015 Feb; 15(2):255-65. PubMed ID: 25362968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isotopic biomarker discovery and application in translational medicine.
    Bayele HK; Chiti A; Colina R; Fernandes O; Khan B; Krishnamoorthy R; Ozdağ H; Padua RA
    Drug Discov Today; 2010 Feb; 15(3-4):127-36. PubMed ID: 20038454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo systems biology approaches to chronic immune/inflammatory pathophysiology.
    Starchenko A; Lauffenburger DA
    Curr Opin Biotechnol; 2018 Aug; 52():9-16. PubMed ID: 29494996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational biology for cardiovascular biomarker discovery.
    Azuaje F; Devaux Y; Wagner D
    Brief Bioinform; 2009 Jul; 10(4):367-77. PubMed ID: 19276200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges and opportunities for oncology biomarker discovery.
    Deyati A; Younesi E; Hofmann-Apitius M; Novac N
    Drug Discov Today; 2013 Jul; 18(13-14):614-24. PubMed ID: 23280501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translation of neurological biomarkers to clinically relevant platforms.
    Hayes RL; Robinson G; Muller U; Wang KK
    Methods Mol Biol; 2009; 566():303-13. PubMed ID: 20058180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From -omics to personalized medicine in nephrology: integration is the key.
    Pesce F; Pathan S; Schena FP
    Nephrol Dial Transplant; 2013 Jan; 28(1):24-8. PubMed ID: 23229923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular profiling approaches for identifying novel biomarkers.
    Bailey WJ; Ulrich R
    Expert Opin Drug Saf; 2004 Mar; 3(2):137-51. PubMed ID: 15006720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translational bioinformatics in psychoneuroimmunology: methods and applications.
    Yan Q
    Methods Mol Biol; 2012; 934():383-400. PubMed ID: 22933157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric systems medicine: evaluating needs and opportunities using congenital heart block as a case study.
    Tegnér J; Abugessaisa I
    Pediatr Res; 2013 Apr; 73(4 Pt 2):508-13. PubMed ID: 23370412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-platform method for identifying candidate network biomarkers for prostate cancer.
    Jin G; Zhou X; Cui K; Zhang XS; Chen L; Wong ST
    IET Syst Biol; 2009 Nov; 3(6):505-12. PubMed ID: 19947776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.